Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's ...
A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...
Meanwhile, Boston Scientific is still waiting for antitrust regulators to conclude their review of its proposal to buy Axonics, which was announced in January.
The prevalence of inflammatory bowel disease (IBD) in the United States is approximately 0.9% of the general population, with ulcerative colitis (UC) affecting 0.4% and Crohn’s disease (CD) affecting ...